Business Wire

Thales Unveils PureFlyt, the Brain of Tomorrow’s Aircraft

25.11.2019 21:33:00 EET | Business Wire | Press release

Share

Innovdays -Thales is unveiling PureFlyt, the Flight Management System (FMS) of the future, specifically designed to efficiently manage aircraft in a connected aerospace ecosystem and in increasingly crowded skies. Indeed, with the global commercial aircraft fleet forecast to double by 2030, and the use of drones set to rapidly grow, we will be entering an era in which millions of aircraft movements are recorded each day.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191125005715/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

© Thales

Combining extensive knowledge of Avionics, Connectivity, Air Traffic management and 40-year Flight Management System expertise, Thales has developed PureFlyt, an entirely connected FMS, designed to offer airframers and airlines the best combination of safety, security, and fuel and operations efficiency. PureFlyt will allow crews to make better decisions using more sources of information, will bring improved performance and reactivity to the aircraft during complex phases of flight and will calculate alternative trajectories in real time to propose or react quickly to changes of plan. Providing pilots with the right information at the right time heightens trust in the computed trajectory, enhancing efficiency and reducing pilot workload throughout all flight phases.

One of the core innovations making PureFlyt a game changer in the FMS world is its ability to draw on both onboard and open-world data, such as weather information. By combining the integrity of the FMS and the agility and power of Electronic Flight Bag flight functionalities, aircraft trajectory can be permanently controlled, adapted and enhanced, resulting in optimised flight, decreased fuel consumption and improved passenger comfort.

While being a technological breakthrough, PureFlyt enjoys an unparalleled maturity level. Using massive testing and artificial intelligence technologies to simulate 2 billion test cases enabled accumulating an invaluable experience, equivalent of 100 million actual flight hours.

Cyber-secure by design, PureFlyt has also been designed to be future-proof, accommodating the implementation of concepts such as the Initial 4D (I4D) trajectory management methods currently being researched by SESAR (Single European Sky ATM Research) in the EU and NextGen in the US. By increasing the accuracy of flight in four dimensions, the fourth dimension being time, PureFlyt will enable more effectiveness in maintaining optimal distance between aircraft, particularly in the demanding phases of departure and approach.

PureFlyt will be available for entry into service in 2024, for both linefit and retrofit.

“In the air, the digital revolution has only just begun. A paradigm shift in onboard cockpit electronics is taking place in the connected airspace and PureFlyt is at the forefront of this digital new age, leading the next generation of Flight Management System that truly makes the aircraft a node of connectivity. By computing and sharing vast amounts of data, PureFlyt will make flights safer, greener, easier for the pilots to manage, more profitable for airlines and, all this, ultimately for the full benefits of passengers” declared Jean-Paul Ebanga, Thales Vice-President Flight Avionics.

For more information please visit:
https://www.thalesgroup.com/en/group/magazine/quantum-leap-flight-management

About Thales

The people we all rely on to make the world go round – they rely on Thales. Our customers come to us with big ambitions: to make life better, to keep us safer. Combining a unique diversity of expertise, talents and cultures, our architects design and deliver extraordinary high technology solutions. Solutions that make tomorrow possible, today. From the bottom of the oceans to the depth of space and cyberspace, we help our customers think smarter and act faster - mastering ever greater complexity and every decisive moment along the way.

Thales generated revenues of €19 billion in 2018 with 80,000 employees in 68 countries.

PLEASE VISIT

Thales Group
Thales Press
Download HD photos

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PRESS
Thales, Media Relations
Civil Aerospace
Giaime Porcu
+33 1 57 77 92 18
giaime.porcu@thalesgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release

Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 17:13:00 EEST | Press release

For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and more practical: what it takes to make a specific, high-stakes determination reliable, fast and affordable at scale. A vertical, domain-focused process, gro

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 17:08:00 EEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 17:00:00 EEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by market capitalization and is home to world-leading companies such as Samsung Electr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye